Carregant...
Aligning the Economic Value of Companion Diagnostics and Stratified Medicines
The twin forces of payors seeking fair pricing and the rising costs of developing new medicines has driven a closer relationship between pharmaceutical companies and diagnostics companies, because stratified medicines, guided by companion diagnostics, offer better commercial, as well as clinical, ou...
Guardat en:
| Publicat a: | J Pers Med |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2012
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4251370/ https://ncbi.nlm.nih.gov/pubmed/25562363 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jpm2040257 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|